1-3 of 3
Thomas Lynch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Noncoding RNAs in Prostate Cancer: The Long and the Short of It

Eva M. Bolton, Alexandra V. Tuzova, Anna L. Walsh, Thomas Lynch, Antoinette S. Perry
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (1): 35–43.
https://doi.org/10.1158/1078-0432.CCR-13-1989
Published: 05 January 2014
View article titled, Noncoding RNAs in Prostate Cancer: The Long and the Short of It
Open the PDF for Noncoding RNAs in Prostate Cancer: The Long and the Short of It in another window
Journal Articles

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

Scott J. Rodig, Mari Mino-Kenudson, Sanja Dacic, Beow Y. Yeap, Alice Shaw, Justine A. Barletta, Hannah Stubbs, Kenny Law, Neal Lindeman, Eugene Mark, Pasi A. Janne, Thomas Lynch, Bruce E. Johnson, A. John Iafrate, Lucian R. Chirieac
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5216–5223.
https://doi.org/10.1158/1078-0432.CCR-09-0802
Published: 12 August 2009
View article titled, Unique Clinicopathologic Features Characterize <em>ALK</em>-Rearranged Lung Adenocarcinoma in the Western Population
Open the PDF for Unique Clinicopathologic Features Characterize <em>ALK</em>-Rearranged Lung Adenocarcinoma in the Western Population in another window
Includes: Supplementary data
Journal Articles

A Phase I Clinical Trial of Sequentially Administered Doxorubicin and Topotecan in Refractory Solid Tumors

Michael V. Seiden, Shu-Wing Ng, Jeffrey G. Supko, David P. Ryan, Jeffrey W. Clark, Thomas Lynch, Kuan-Chun Huang, David Kwiatkowski, Arthur Skarin, Joseph P. Eder, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 691–697.
Published: 01 March 2002
View article titled, A Phase I Clinical Trial of Sequentially Administered Doxorubicin and Topotecan in Refractory Solid Tumors
Open the PDF for A Phase I Clinical Trial of Sequentially Administered Doxorubicin and Topotecan in Refractory Solid Tumors in another window